Brief: Anixa Biosciences Announces Completion Of Final Patient Visit In Breast Cancer Vaccine Clinical Trial
07/10/2025 13:50
Oct 7 (Reuters) - Anixa Biosciences Inc ANIX.O: ANIXA BIOSCIENCES ANNOUNCES COMPLETION OF FINAL PATIENT VISIT IN BREAST CANCER VACCINE CLINICAL TRIAL Source text: ID:nPn4xnBl6a Further company coverage: ANIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine